nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—Breast disorder—Methotrexate—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Vigabatrin—Malaise—Prednisolone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Vigabatrin—Vertigo—Prednisolone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Vigabatrin—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Vigabatrin—Eye disorder—Betamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Vigabatrin—Back pain—Triamcinolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Vigabatrin—Convulsion—Prednisolone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Vigabatrin—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Vigabatrin—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Vigabatrin—Discomfort—Prednisolone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Vigabatrin—Angioedema—Triamcinolone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Vigabatrin—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Vigabatrin—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Vigabatrin—Hallucination—Prednisone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Vigabatrin—Malaise—Triamcinolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Vigabatrin—Malaise—Methylprednisolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Vigabatrin—Vertigo—Triamcinolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Vigabatrin—Vertigo—Methylprednisolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Vigabatrin—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Vigabatrin—Oedema—Prednisolone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Vigabatrin—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Vigabatrin—Cough—Triamcinolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Vigabatrin—Convulsion—Triamcinolone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Vigabatrin—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Vigabatrin—Myalgia—Triamcinolone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Vigabatrin—Pneumonia—Methotrexate—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Vigabatrin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Vigabatrin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Vigabatrin—Eye disorder—Prednisone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Vigabatrin—Anxiety—Methylprednisolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Vigabatrin—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Vigabatrin—Infestation—Methotrexate—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Vigabatrin—Drowsiness—Methotrexate—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Vigabatrin—Depression—Methotrexate—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Vigabatrin—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Vigabatrin—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Vigabatrin—Discomfort—Triamcinolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Vigabatrin—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Vigabatrin—Angioedema—Dexamethasone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Vigabatrin—Angioedema—Betamethasone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Vigabatrin—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Vigabatrin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Vigabatrin—Malaise—Dexamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Vigabatrin—Malaise—Betamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Vigabatrin—Oedema—Triamcinolone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Vigabatrin—Vertigo—Dexamethasone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Vigabatrin—Vertigo—Betamethasone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Vigabatrin—Infection—Triamcinolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Vigabatrin—Infection—Methylprednisolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Vigabatrin—Insomnia—Prednisolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Vigabatrin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Vigabatrin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Vigabatrin—Mental disorder—Prednisone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Vigabatrin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Vigabatrin—Malnutrition—Prednisone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Vigabatrin—Convulsion—Dexamethasone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Vigabatrin—Convulsion—Betamethasone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Vigabatrin—Myalgia—Dexamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Vigabatrin—Myalgia—Betamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Vigabatrin—Anxiety—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Vigabatrin—Anxiety—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Vigabatrin—Discomfort—Dexamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Vigabatrin—Discomfort—Betamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Vigabatrin—Pain—Prednisolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Vigabatrin—Vision blurred—Prednisone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Vigabatrin—Oedema—Dexamethasone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Vigabatrin—Oedema—Betamethasone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Vigabatrin—Insomnia—Triamcinolone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Vigabatrin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Vigabatrin—Infection—Betamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Vigabatrin—Infection—Dexamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Vigabatrin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Vigabatrin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Vigabatrin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Vigabatrin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Vigabatrin—Visual impairment—Methotrexate—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Vigabatrin—Anaemia—Prednisone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Vigabatrin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Vigabatrin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Vigabatrin—Agitation—Prednisone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Vigabatrin—Angioedema—Prednisone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Vigabatrin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Vigabatrin—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Vigabatrin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Vigabatrin—Malaise—Prednisone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Vigabatrin—Vertigo—Prednisone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Vigabatrin—Eye disorder—Methotrexate—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Vigabatrin—Tinnitus—Methotrexate—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Vigabatrin—Urticaria—Prednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Vigabatrin—Fatigue—Triamcinolone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Vigabatrin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Vigabatrin—Pain—Triamcinolone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Vigabatrin—Convulsion—Prednisone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Vigabatrin—Myalgia—Prednisone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Vigabatrin—Arthralgia—Prednisone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Vigabatrin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Vigabatrin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Vigabatrin—Anxiety—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Vigabatrin—Insomnia—Dexamethasone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Vigabatrin—Insomnia—Betamethasone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Vigabatrin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Vigabatrin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Vigabatrin—Discomfort—Prednisone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Vigabatrin—Mental disorder—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Vigabatrin—Malnutrition—Methotrexate—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Vigabatrin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Vigabatrin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Vigabatrin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Vigabatrin—Urticaria—Triamcinolone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Vigabatrin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Vigabatrin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Vigabatrin—Oedema—Prednisone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Vigabatrin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Vigabatrin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Vigabatrin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Vigabatrin—Infection—Prednisone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Vigabatrin—Back pain—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Vigabatrin—Fatigue—Dexamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Vigabatrin—Fatigue—Betamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Vigabatrin—Pain—Betamethasone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Vigabatrin—Pain—Dexamethasone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Vigabatrin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Vigabatrin—Skin disorder—Prednisone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Vigabatrin—Vision blurred—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Vigabatrin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Vigabatrin—Anaemia—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Vigabatrin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Vigabatrin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Vigabatrin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Vigabatrin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Vigabatrin—Malaise—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Vigabatrin—Vertigo—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Vigabatrin—Urticaria—Betamethasone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Vigabatrin—Urticaria—Dexamethasone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Vigabatrin—Dizziness—Prednisolone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Vigabatrin—Asthenia—Triamcinolone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Vigabatrin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Vigabatrin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Vigabatrin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Vigabatrin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Vigabatrin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Vigabatrin—Insomnia—Prednisone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Vigabatrin—Paraesthesia—Prednisone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Vigabatrin—Pruritus—Triamcinolone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Vigabatrin—Cough—Methotrexate—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Vigabatrin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Vigabatrin—Convulsion—Methotrexate—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Vigabatrin—Dyspepsia—Prednisone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Vigabatrin—Arthralgia—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Vigabatrin—Myalgia—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Vigabatrin—Chest pain—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Vigabatrin—Decreased appetite—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Vigabatrin—Rash—Prednisolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Vigabatrin—Dermatitis—Prednisolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Vigabatrin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Vigabatrin—Fatigue—Prednisone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Vigabatrin—Headache—Prednisolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Vigabatrin—Discomfort—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Vigabatrin—Constipation—Prednisone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Vigabatrin—Confusional state—Methotrexate—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Vigabatrin—Dizziness—Triamcinolone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Vigabatrin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Vigabatrin—Infection—Methotrexate—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Vigabatrin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Vigabatrin—Asthenia—Betamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Vigabatrin—Asthenia—Dexamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Vigabatrin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Vigabatrin—Nausea—Prednisolone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Vigabatrin—Pruritus—Betamethasone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Vigabatrin—Pruritus—Dexamethasone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Vigabatrin—Skin disorder—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Vigabatrin—Vomiting—Triamcinolone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Vigabatrin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Vigabatrin—Rash—Triamcinolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Vigabatrin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Vigabatrin—Rash—Methylprednisolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Vigabatrin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Vigabatrin—Urticaria—Prednisone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Vigabatrin—Headache—Triamcinolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Vigabatrin—Headache—Methylprednisolone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Vigabatrin—Abdominal pain—Prednisone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Vigabatrin—Body temperature increased—Prednisone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Vigabatrin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Vigabatrin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Vigabatrin—Dizziness—Dexamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Vigabatrin—Dizziness—Betamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Vigabatrin—Insomnia—Methotrexate—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Vigabatrin—Nausea—Triamcinolone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Vigabatrin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Vigabatrin—Nausea—Methylprednisolone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Vigabatrin—Somnolence—Methotrexate—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Vigabatrin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Vigabatrin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Vigabatrin—Vomiting—Dexamethasone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Vigabatrin—Vomiting—Betamethasone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Vigabatrin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000995	0.000995	CcSEcCtD
Vigabatrin—Rash—Betamethasone—ankylosing spondylitis	0.000992	0.000992	CcSEcCtD
Vigabatrin—Rash—Dexamethasone—ankylosing spondylitis	0.000992	0.000992	CcSEcCtD
Vigabatrin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000991	0.000991	CcSEcCtD
Vigabatrin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000991	0.000991	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000988	0.000988	CcSEcCtD
Vigabatrin—Fatigue—Methotrexate—ankylosing spondylitis	0.000987	0.000987	CcSEcCtD
Vigabatrin—Headache—Betamethasone—ankylosing spondylitis	0.000985	0.000985	CcSEcCtD
Vigabatrin—Headache—Dexamethasone—ankylosing spondylitis	0.000985	0.000985	CcSEcCtD
Vigabatrin—Asthenia—Prednisone—ankylosing spondylitis	0.000983	0.000983	CcSEcCtD
Vigabatrin—Pain—Methotrexate—ankylosing spondylitis	0.000979	0.000979	CcSEcCtD
Vigabatrin—Pruritus—Prednisone—ankylosing spondylitis	0.000969	0.000969	CcSEcCtD
Vigabatrin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000943	0.000943	CcSEcCtD
Vigabatrin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000937	0.000937	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000936	0.000936	CcSEcCtD
Vigabatrin—Nausea—Betamethasone—ankylosing spondylitis	0.000934	0.000934	CcSEcCtD
Vigabatrin—Nausea—Dexamethasone—ankylosing spondylitis	0.000934	0.000934	CcSEcCtD
Vigabatrin—Urticaria—Methotrexate—ankylosing spondylitis	0.000909	0.000909	CcSEcCtD
Vigabatrin—Dizziness—Prednisone—ankylosing spondylitis	0.000906	0.000906	CcSEcCtD
Vigabatrin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000905	0.000905	CcSEcCtD
Vigabatrin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000905	0.000905	CcSEcCtD
Vigabatrin—Vomiting—Prednisone—ankylosing spondylitis	0.000871	0.000871	CcSEcCtD
Vigabatrin—Rash—Prednisone—ankylosing spondylitis	0.000863	0.000863	CcSEcCtD
Vigabatrin—Dermatitis—Prednisone—ankylosing spondylitis	0.000863	0.000863	CcSEcCtD
Vigabatrin—Headache—Prednisone—ankylosing spondylitis	0.000858	0.000858	CcSEcCtD
Vigabatrin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000843	0.000843	CcSEcCtD
Vigabatrin—Asthenia—Methotrexate—ankylosing spondylitis	0.000821	0.000821	CcSEcCtD
Vigabatrin—Nausea—Prednisone—ankylosing spondylitis	0.000813	0.000813	CcSEcCtD
Vigabatrin—Pruritus—Methotrexate—ankylosing spondylitis	0.00081	0.00081	CcSEcCtD
Vigabatrin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000783	0.000783	CcSEcCtD
Vigabatrin—Dizziness—Methotrexate—ankylosing spondylitis	0.000757	0.000757	CcSEcCtD
Vigabatrin—Vomiting—Methotrexate—ankylosing spondylitis	0.000728	0.000728	CcSEcCtD
Vigabatrin—Rash—Methotrexate—ankylosing spondylitis	0.000722	0.000722	CcSEcCtD
Vigabatrin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000721	0.000721	CcSEcCtD
Vigabatrin—Headache—Methotrexate—ankylosing spondylitis	0.000717	0.000717	CcSEcCtD
Vigabatrin—Nausea—Methotrexate—ankylosing spondylitis	0.00068	0.00068	CcSEcCtD
